The Proteonomix Mission

The mission of Proteonomix, Inc. is to achieve a leadership position in life enhancement regenerative stem cell therapies, services, and products through a combination of first to market technologies, and innovative clinical trial strategies.

Primary Focus

We are primarily focused on developing therapies and products based upon the use of human stem cells and their derivatives with an initial focus on diabetes and cardiac diseases.

	Stem cell therapy provides much promise for the treatment of diseases previously regarded as incurable. Many of the currently incurable diseases associated with aging are caused by the degeneration of specific cell types in the body. These diseases include but are not limited to cancer, heart disease, diabetes, and autoimmune conditions. Stem cell therapy provides much promise for the treatment of diseases previously regarded as incurable.
	StromaCel™ Cardiac Treatment We are developing our Post Myocardial Infarction treatment, StromaCel™. This treatment is taken intravenously in the first 14 days following an infarction to assist to rebuild the underlying vascular tissuein order to increase cardiac muslcle recovery. We are currently seeking funding to make application for FDA Clinical trials on this promising treatment.
	Diabetes Research We have been in research and development for many years on a treatment for all forms of diabetes. Recent breakthroughs in our research have encouraged us to seek funding for large animal trials in anticipation of Phase 1 trials to follow.
	Other Areas of Development Proteonomix also looks at overall health and wellness. As our Proteoderm products comes to market for skin rejuvination and anti-aging, we are also developing additional products to improve the quality of our clients lives.